0001209191-22-046711.txt : 20220818
0001209191-22-046711.hdr.sgml : 20220818
20220818173757
ACCESSION NUMBER: 0001209191-22-046711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220818
DATE AS OF CHANGE: 20220818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kulkarni Samarth
CENTRAL INDEX KEY: 0001682019
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 221178275
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-16
0
0001674416
CRISPR Therapeutics AG
CRSP
0001682019
Kulkarni Samarth
C/O CRISPR THERAPEUTICS, INC.
105 W FIRST STREET
BOSTON
MA
02127
1
1
0
0
Chief Executive Officer
Restricted Stock Units
2022-08-16
4
A
0
25000
0.00
A
Common Shares
25000
25000
D
Performance-based Restricted Stock Units
2022-08-16
4
A
0
150000
0.00
A
Common Shares
150000
150000
D
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
The restricted stock units shall vest in full on August 16, 2025, subject to continued service to the Company or any of its subsidiaries.
Each performance-based restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
Represents the maximum number of shares of CRSP Common Shares that may be awarded upon the achievement of performance conditions.
This grant is subject to both time- and performance-based vesting. Performance-based restricted stock units will vest subject to the terms and conditions of the grant agreement evidencing the award and the Company's 2018 Stock Option and Incentive Plan. The performance conditions shall be deemed satisfied subject to achievement of certain share price targets on or before the third anniversary of the date of grant. All of the performance-based restricted stock units that have satisfied the applicable performance-based criteria shall be deemed vested on the third anniversary of the date of grant, subject to continued service to the Company or any of its subsidiaries through such date.
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
2022-08-18